Multiple Myeloma Patients Ineligible for Randomized Controlled Trials Have Poorer Outcomes Irrespective of Treatment

Title : Multiple Myeloma Patients Ineligible for Randomized Controlled Trials Have Poorer Outcomes Irrespective of Treatment

Source : Cochrane
ID : 30001984
Authors : Malecek, , M-K, Fiala, M, Schroeder, M, Dukeman, J, Ghobadi, A, Stockerl-Goldstein, K, Wildes, T; Vij, R
Year : 2018
Disease Category : Cancer
Focused Population : Not Specified
Priori/Posteriori : Priori
Single-study Generalibility? : Multiple
Score/Non-Score : Non-score
Tutorial/Method : NHANES_T2D
Compared general demographic and patient characteristics : Yes
Compared disease-specific clinical characteristics : Yes
Compared adverse events : No
Compared outcomes/treatment effect (including survival) : No
Eligible patients (by applying criteria) vs. ineliglble patients (by applying criteria) : Yes
Real-world data sources : IA11 of the Multiple Myeloma Research Foundation (MMRF) CoMMpass study
Target Population Data Type Levels : International